Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01329835
Other study ID # GWG32011
Secondary ID
Status Recruiting
Phase N/A
First received March 30, 2011
Last updated December 5, 2011
Start date March 2008
Est. completion date December 2013

Study information

Verified date July 2008
Source Limburg Catholic University College
Contact n/a
Is FDA regulated No
Health authority Belgium: Medical Ethics Committee Katholieke Universiteit Leuven
Study type Interventional

Clinical Trial Summary

Prepregnancy obesity, defined as a body mass index (BMI) of 30kg/m² or more, shows a strong association with pregnancy and birth complications for both the mother and her child. Most consequently reported maternal risks include an increased risk for gestational diabetes, hypertension and pre-eclampsia, increased incidence of induction of labour, operative delivery, postpartum haemorrhage, anaesthetic risks as well as risk for infections and thromboembolic complications. Fetal risks include miscarriage, neural-tube defects, heart defects, macrosomia and stillbirth. Initiation and continuation of breastfeeding is more complicated in obese women than in normal weight women. Also in later life chronic diseases can put the mother and her baby's health at risk. The Institute Of Medicine (IOM) guidelines suggest a gestational weight gain (GWG) to be limited to 5 - 9 kg (11-19,8 lb) in obese women in order to minimize the synergetic negative health consequences of excessive weight gain for both the obese mother and her child. Preventing excessive weight gain during pregnancy and postpartum weight retention is also important in the prevention of overweight and obesity among women of reproductive age. Obese women in general have a poor diet quality and are more exposed to psychosocial factors like anxiety and feelings of depression than normal weight women.

The aim of this project is to perform a randomized controlled trial (RCT) in order to evaluate the effects of life-style intervention (psycho-education by a midwife during 4 prenatal sessions) on pregnancy and birth outcomes. Main dependent variables are gestational weight gain and anxiety and depression. Obesity is a modifiable risk factor and optimizing an adequate gestational weight gain with attention to psycho-social factors, can reduce the need for adverse perinatal outcomes.


Recruitment information / eligibility

Status Recruiting
Enrollment 180
Est. completion date December 2013
Est. primary completion date April 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- Less than 15 weeks pregnant

Exclusion Criteria:

- Multiple pregnancy

- Preexisting diabetes

- Primary need for nutritional advice

- Inadequate knowledge of Dutch language

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Behavioral:
Lifestyle counseling
4 prenatal sessions based on principles of motivational interviewing and positive reinforcement
Other:
brochure
brochure given after randomization

Locations

Country Name City State
Belgium St-Jans Hospital ZOL Genk Limburg
Belgium Jessa Hospital Hasselt Limburg
Belgium SFZ Heusden Limburg

Sponsors (2)

Lead Sponsor Collaborator
Limburg Catholic University College PHL University College

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Gestational weight gain Weight just before delivery minus prepregnancy weight For the duration of pregnancy, an expected average of 40 weeks Yes
Secondary Evolutions in anxiety and depression during pregnancy STAI (Spielberger) ==> anxiety EPDS ==> depression During pregnancy on fixed time points: trimester 1 (before 15 weeks of gestation), trimester 2 (between 18 and 28 weeks of gestation) and trimester 3 (between 30 - 34 weeks of gestation) Yes
See also
  Status Clinical Trial Phase
Terminated NCT03706872 - Efficacy of an App for Monitoring Physical Activity and Weight of Obese Pregnant Women (Pas&Pes) N/A